FOXO4-DRI 10mg

Description

⚠️ FOR RESEARCH PURPOSES ONLY — NOT FOR HUMAN CONSUMPTION

Research Background

FOXO4-DRI is a retro-inverso peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. Used in senolytic research to study mechanisms of senescent cell apoptosis and cellular clearance.

All research summaries are for informational purposes only and do not constitute medical claims. Vexar Lab compounds are not approved for human use.

Compound Data

• CAS Number: N/A
• Molecular Formula: Retro-inverso modified peptide
• Molecular Weight: N/A
• Sequence / Structure: D-retro-inverso FOXO4 helix-2 domain
• Appearance: White lyophilised powder
• Solubility: DMSO soluble; dilute in aqueous buffer

Purity & Testing

• Purity: ≥95% HPLC-UV
• Analysis: HPLC-UV
• Mass Confirmation: ESI-MS

Storage & Handling

• Sealed: −20°C away from light and moisture
• Reconstituted: 4°C use within 14 days — unstable in solution
• Stability: 12 months

Reconstitution Guide

Dissolve in DMSO first, then dilute in aqueous buffer. Store lyophilised at −20°C. Reconstituted solution unstable — use within 14 days.

For research purposes only — not for human consumption.

Ordering

Minimum order £300. £45 flat worldwide shipping. Custom vial labelling available (+3 weeks lead time). Unlabelled orders dispatch within 1 week.

Legal Disclaimer

FOR RESEARCH USE ONLY. Not for human consumption. Not a medicine. Not intended to diagnose, treat, cure or prevent any disease or medical condition. By purchasing you confirm you are a qualified research professional using this compound for legitimate in-vitro laboratory research purposes only. Vexar Lab accepts no liability for misuse.